BRCA1/2 testing is covered mostly for affected individuals with a family history of breast cancer and occasionally for healthy individuals with suspected breast cancer and/or breast cancer history (Centers for Medicare & Medicaid Services, 2018; Local Coverage Determination (LCD); Beattie et al., 2012; Meckley and Neumann, 2010). The gene discussed is BRCA1; the disease is breast cancer.